MedPath

ACTAVIS INC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Fasting Conditions

First Posted Date
2009-03-18
Last Posted Date
2010-08-16
Lead Sponsor
Actavis Inc.
Target Recruit Count
30
Registration Number
NCT00864344
Locations
🇺🇸

CEDRA Clinical Research, LLC, Austin, Texas, United States

A Relative Bioavailability Study of Cetirizine HCl 10 mg Tablets Under Non-fasting Conditions

First Posted Date
2009-03-18
Last Posted Date
2010-08-16
Lead Sponsor
Actavis Inc.
Target Recruit Count
26
Registration Number
NCT00863902
Locations
🇺🇸

AAIPharma Inc.- AAI Clinic, Morrisville, North Carolina, United States

A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Ramipril10 mg Capsules, single dose
Drug: Atlace® 10 mg capsules, single dose
First Posted Date
2009-03-18
Last Posted Date
2010-08-16
Lead Sponsor
Actavis Inc.
Target Recruit Count
40
Registration Number
NCT00864162
Locations
🇺🇸

CEDRA Clinical Research, LLC, Austin, Texas, United States

A Relative Bioavailability Study of Ramipril 10 mg Capsules Administered Orally as a Sprinkle on Applesauce

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Ramipril10 mg Capsules, single dose
Drug: Atlace® 10 mg capsules, single dose
First Posted Date
2009-03-18
Last Posted Date
2010-08-16
Lead Sponsor
Actavis Inc.
Target Recruit Count
40
Registration Number
NCT00863915
Locations
🇺🇸

CEDRA Clinical Research, LLC, Austin, Texas, United States

A Relative Bioavailability Study of Cetirizine HCl 10 mg Tablets Under Fasting Conditions

First Posted Date
2009-03-18
Last Posted Date
2010-08-16
Lead Sponsor
Actavis Inc.
Target Recruit Count
26
Registration Number
NCT00864279
Locations
🇺🇸

AAIPharma Inc.- AAI Clinic, Morrisville, North Carolina, United States

A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Non-fasting Conditions

First Posted Date
2009-03-18
Last Posted Date
2010-08-16
Lead Sponsor
Actavis Inc.
Target Recruit Count
36
Registration Number
NCT00864149
Locations
🇨🇦

Biovail Contract Research (A Division of Biovail Corporation), Toronto, Ontario, Canada

A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Grifulvin V® 125 mg/5 mL Suspension, single dose
First Posted Date
2009-03-18
Last Posted Date
2010-08-16
Lead Sponsor
Actavis Inc.
Target Recruit Count
50
Registration Number
NCT00864071
Locations
🇨🇦

Biovail Contract Research (A Division of Biovail Corporation), Toronto, Ontario, Canada

Pivotal Bioequivalence Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects

First Posted Date
2009-03-18
Last Posted Date
2019-07-09
Lead Sponsor
Actavis Inc.
Target Recruit Count
224
Registration Number
NCT00864500
Locations
🇺🇸

Novum Pharmaceutical Research Services, Houston, Texas, United States

Comparative Study to Evaluate KADIAN and Avinza in Healthy Adults

First Posted Date
2008-10-31
Last Posted Date
2020-07-16
Lead Sponsor
Actavis Inc.
Target Recruit Count
40
Registration Number
NCT00782548
Locations
🇺🇸

MDS Pharma Services, Lincoln, Nebraska, United States

Comparison of KADIAN 100 mg When Dosed With Alcohol Under Fasting and Fed Conditions Compared to Water

First Posted Date
2008-10-07
Last Posted Date
2020-07-16
Lead Sponsor
Actavis Inc.
Target Recruit Count
32
Registration Number
NCT00768183
Locations
🇺🇸

MDS Pharma Services, Lincoln, Nebraska, United States

© Copyright 2025. All Rights Reserved by MedPath